Orders from 100 GBP Free delivery from 205 GBP Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

2-FMA

C10H14FN CAS 1017176-48-5 Analytical reference material — not for human consumption
Preferred name
2-FMA
IUPAC name
1-(2-fluorophenyl)-N-methylpropan-2-amine
Parent CAS number (reference)
1017176-48-5
Molecular formula
C10H14FN
Molecular weight
167.22 g/mol
InChIKey
XNWIKJYFOIDUGD-UHFFFAOYSA-N
PubChem
CID 24257263
Source
PubChem
Verified synonyms & catalog abbreviations
2-Fluoromethamphetamine 2FMA 2 FMA

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

2-FMA

Stimulant (dopamine/norepinephrine releaser, low serotonin) Ring-fluorinated methamphetamine (ortho-fluoro)
Verified PubChem & CAS Identity C10H14FN · CAS 1017176-48-5 · CID 24257263
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 167.22 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

2-FMA is the ortho-fluoro analogue of methamphetamine and the N-methyl homologue of 2-FA. Published human transporter numbers are sparse. The observed profile is a long, functional dopamine/norepinephrine stimulant with little serotonergic warmth: focus, wakefulness, appetite loss, and a flat mood rather than an MDMA-like roll. It is less mood-elevating than 3-FA or 4-FA and much less entactogenic than 4-FMA.

Biotransformation & Active Metabolites

Presumed to undergo typical amphetamine N-demethylation and oxidative deamination. It is not a prodrug of 2-FA in any quantitative brackets sense, and a 2-FA oral chart (common 30–50 mg, 2–4 hours) does not describe this longer compound.

Temporal Pharmacokinetics

Long, clear, low-mood elevation stimulant. Wakefulness and task focus with vasoconstriction and a hard offset, not an entactogen.

  1. Onset 30–60 minutes
  2. Peak Window 2.5–4 hours
  3. Total Window 7–9 hours
  4. Residual / Half-Life Residual stimulation 4–12 hours. A formal human half-life is not published; the practical problem is next-night insomnia.

Oral threshold 5 mg, light 5–15 mg, common 15–30 mg, strong 30–50 mg, heavy above 50 mg. The total course is 7–9 hours with 4–12 hours of after-effects. A second dose taken to extend the afternoon lands in the insomnia window.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
5 mg
Cognitive & Sensory

Slight wakefulness and a cleaner attention span.

Somatic & Autonomic

Mild appetite loss and a small pulse increase.

Light
5–15 mg
Cognitive & Sensory

Functional alertness, motivation, and little emotional color.

Somatic & Autonomic

Dry mouth, cold fingers, and suppressed hunger.

Common Reference
15–30 mg
Cognitive & Sensory

Sustained focus, talkativeness without much mood elevation, and a forced wakefulness that outlasts the useful part.

Somatic & Autonomic

Tachycardia, blood-pressure rise, bruxism, and sweating.

Strong
30–50 mg
Cognitive & Sensory

Scattered focus, irritability, and stimulant anxiety replacing the 'clean' feeling.

Somatic & Autonomic

Pronounced vasoconstriction, tremor, urinary hesitation, and a long inability to sleep.

Heavy / Toxic Zone
50 mg+
Cognitive & Sensory

Agitation, paranoia, and compulsive repeated exposure thoughts.

Somatic & Autonomic

Hypertensive strain, chest tightness, severe insomnia, and seizure risk with tramadol or an MAOI.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

25x-NBOMe and 25x-NBOH

Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Elevated Hazard — Avoid

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Caution / Receptor Attenuation

Cannabis

Often increases heart rate and paranoid thought on the offset.

SSRIs and SNRIs

Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.

Structural Isomer & Sibling Comparison

2-FMA is the long functional fluoro stimulant: common 15–30 mg oral and 7–9 hours, little serotonin. 4-FMA (common 50–100 mg) is more entactogenic and more concerning for the heart. 3-FA (common 30–50 mg, 4–6 hours) is more classically mood-elevating and dopaminergic. 4-FA becomes entactogenic only around 100 mg and has a stroke signal above the strong band. None of those oral numbers are interchangeable.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Dopaminergic stimulant tolerance builds with repeated days, halves over roughly 3–7 days, and approaches baseline in 1–2 weeks, with cross-tolerance to amphetamines and other catecholamine stimulants. Psychological dependence and crash fatigue are the dependence pattern. It does not reset serotonin the way an MDMA weekend does, but daily use still produces a flat, vasoconstricted insomnia cycle.

Comprehensive Analytical & Toxicological Monograph

2-FMA (1-(2-fluorophenyl)-N-methylpropan-2-amine; CAS 1017176-48-5, PubChem CID 24257263) is the ortho-fluorinated methamphetamine supplied as pure powder or crystals (C10H14FN, 167.22 g/mol). It behaves as a long dopamine/norepinephrine stimulant with little serotonergic warmth. PsychonautWiki oral bands are threshold 5 mg, light 5–15 mg, common 15–30 mg, strong 30–50 mg, and heavy above 50 mg. Onset is 30–60 minutes and the total course is 7–9 hours, followed by 4–12 hours of residual wakefulness. It is not 4-FMA, not the shorter 3-FA, and not 4-FA. Do not combine with MAOIs, tramadol, other stimulants, or 25x-NBOMe.

Chemical Architecture & Structural Profile

2-FMA (1-(2-fluorophenyl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C10H14FN and a molar mass of 167.22 g/mol. The parent molecule is indexed under CAS registry number 1017176-48-5 and in the NCBI PubChem database as CID 24257263 (Standard InChIKey: XNWIKJYFOIDUGD-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H14FN) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1017176-48-5), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 2-FMA is indexed within the Amphetamine, Substituted amphetamines structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)